Oliver Healthcare Packaging’s Post

💉 AstraZeneca’s FluMist Receives Approval for Self-Administration! A major step forward in flu prevention, AstraZeneca’s FluMist has been approved for self-administration. This move has the potential to significantly boost flu vaccine uptake, making it more convenient for individuals to protect themselves. 🦠💪 As GlobalData Plc highlights, this innovative approach could be a game-changer for flu vaccination, especially during flu season when accessibility matters most. Read more about this important development: 👉 Read the article Sushmita Panda Sakshi Kuchroo Sumana Sarkar Roshun Povaiah Syed Fazal Bari GlobalData Healthcare #Healthcare #Pharma #AstraZeneca #FluMist #Vaccines #SelfAdministration #PublicHealth #Innovation #FluSeason

𝗧𝗿𝗶𝘃𝗮𝗹𝗲𝗻𝘁 𝗙𝗹𝘂 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟭. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The trivalent flu vaccine market is experiencing notable growth, driven by the necessity of preventive healthcare measures against seasonal influenza strains. Offering protection against three flu virus strains, trivalent vaccines are widely administered worldwide. With advancements in vaccine technology and distribution channels, along with increasing awareness about the importance of vaccination, the market is expected to continue expanding to meet global health needs. 𝐓𝐨 𝐊𝐧𝐨𝐰 𝐭𝐡𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐜𝐨𝐩𝐞 𝐚𝐧𝐝 𝐃𝐞𝐦𝐚𝐧𝐝 𝐨𝐟 𝗧𝗿𝗶𝘃𝗮𝗹𝗲𝗻𝘁 𝗙𝗹𝘂 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗠𝗮𝗿𝗸𝗲𝘁. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/gRB2tZV3 *𝗕𝘆 𝗧𝘆𝗽𝗲: Intramuscular Injection, Nasal Spray, Intradermal Shot *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Hospital, Clinic, Public Health Agency, Other *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Sanofi Pasteur MSD, AstraZeneca, CSL, Abbott, GSK, Serum Institute of India Pvt. Ltd. #trivalentfluvaccine #flu #vaccine #influenza #health #immunization #publichealth #fluprevention #vaccination #trivalentvaccine #fluseason #healthcare #diseaseprevention #fluawareness #fluimmunization #vaccineefficacy

US FDA approved on Friday FluMist, the first influenza vaccine that does not need to be administered by a health care provider. MedImmune, the maker of FluMist, plans to offer the vaccine through a third-party pharmacy. In the US individuals willing to get access to the vaccine will complete a screening and eligibility assessment will be approved by the third-party pharmacy. FluMist is the only needle-free seasonal flu vaccine option in the United States and is given intranasally. FluMist is a live attenuated vaccine that contains weakened influenza viruses. The vaccine is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. The FDA recommends that a caregiver administer FluMist to those ages 2 to 17 years old. According to FDA documents FluMist is not approved for use in older persons because in a clinical study (AV009), effectiveness of FluMist to prevent febrile illness was not demonstrated in adults 50 through 64 years of age. In another study of FluMist in persons 65 years of age and older, recipients of the vaccine in this group with underlying high-risk medical in this group had a higher rate of sore throat as compared to controls. https://sco.lt/7nphAm #influenza #medimmune #health #globalhealth #publichealth #medicine #biotechnology #medicine #pharmaceuticals #FDA #CDC #WHO #ECDC #vaccines

📈Increasing uptake: going beyond the classic awareness focus to step change 📈 💬Whenever I speak to someone (client, candidate, colleague) about increasing uptake, their first answer is always “raise awareness” awareness - and in the case of vaccines, “boost vaccine confidence”. 💡Yet, the ingredients to go beyond the incremental ~1% increase are much more multi factorial (👇link below) 1️⃣ HA accountability : setting clear targets and holding stakeholders accountable 2️⃣ Simplified access: for example, pharma based immunization 3️⃣HCP accountability: for example, through the incentivization of GPs to reach specific targets 4️⃣ Awareness of disease burden: e.g. through a strong reporting system that effectively reports cases & burden 5️⃣ Belief in intervention benefits : e.g. establishing trust and showcasing the impact 👩🍳The ingredients are, of course, different depending on the therapeutic area, and the recipe is unique to each country. One thing is common: a multi-pronged approach is necessary. ❓What other ideas do you have beyond increasing awareness ?

𝐖𝐇𝐎 𝐩𝐫𝐞𝐪𝐮𝐚𝐥𝐢𝐟𝐢𝐞𝐬 𝐧𝐞𝐰 𝐨𝐫𝐚𝐥 𝐬𝐢𝐦𝐩𝐥𝐢𝐟𝐢𝐞𝐝 𝐯𝐚𝐜𝐜𝐢𝐧𝐞 𝐟𝐨𝐫 𝐜𝐡𝐨𝐥𝐞𝐫𝐚 A new oral vaccine for cholera has received prequalification by the World Health Organization (WHO) on 12 April. The inactivated oral vaccine Euvichol-S has a similar efficacy to existing vaccines but a simplified formulation, allowing opportunities to rapidly increase production capacity. Read More: https://lnkd.in/dBnMApGP “The new vaccine is the third product of the same family of vaccines we have for cholera in our WHO prequalification list,” said Dr Rogerio Gaspar, Director of the WHO Department for Regulation and Prequalification. “The new prequalification is hoped to enable a rapid increase in production and supply which many communities battling with cholera outbreaks urgently need.” #mededgemea #WHO #choleravaccine #vaccineprequalification #globalhealth #publichealth #VaccinationForAll #diseaseprevention #HealthcareNews #medicalresearch #choleraprevention #cholera #globalvaccination

This #WorldImmunisationWeek celebrates the 50th anniversary of the World Health Organization Expanded/Essential Programme on Immunisation. Click the image below to learn more about the power of vaccines, how they confer safety and how we, at Travel Doctor - TMVC, can help ensure you are well protected on your next international trip. #travelmedicine #travelvaccines #vaccines #WHO

💊Max Daily Health Tips Day 1️⃣1️⃣ Some FACTS ABOUT VACCINES ♻️Vaccines go through extensive clinical trials involving thousands of participants to ensure they are safe and effective before approval. ♻️Health authorities like the WHO and FDA review vaccine data to ensure they meet strict safety standards before being approved for use. ♻️Vaccines have been safely used for decades, protecting millions of people from life-threatening diseases like polio, measles, and smallpox. ♻️After approval, vaccines are continuously monitored for side effects. Any potential risks are quickly addressed by health authorities. ♻️Vaccines contain safe, well-researched ingredients. These include weakened or inactive parts of viruses, which help train the immune system. ♻️Vaccines do not cause the diseases they are designed to protect against, as they only contain harmless components of the virus or bacteria. ♻️Some vaccines contain adjuvants, which boost the immune response. These adjuvants have been used safely in vaccines for years. ♻️Vaccines are continuously reviewed and updated to ensure they remain effective and safe over time. ♻️Vaccines provide long-term protection against diseases, reducing the need for repeated exposure to potentially dangerous infections. ♻️The diseases vaccines prevent, like measles and polio, are far more dangerous than any risks associated with vaccines. ♻️Ingredients like preservatives or stabilizers are used in very tiny, safe amounts to ensure vaccine potency and shelf life. ♻️Vaccines are based on decades of scientific research, ensuring they work safely and effectively. ♻️Vaccine dosages are carefully calculated to be just enough to stimulate immunity without causing harm. ♻️While allergic reactions to vaccines are possible, they are extremely rare and treatable. ♻️Vaccines are approved by panels of independent experts who review all safety and efficacy data. ♻️As new information emerges, vaccines are updated to improve safety and efficacy, ensuring they continue to be safe for all populations. By Max Wellness Foundation #Health #Wellness #PublicHealth #Vaccines #Vaccination #Healthcare #Prevention #StayHealthy #DiseasePrevention #Immunization #SafetyFirst #ProtectYourself #HealthyLiving #HealthMatters #GlobalHealth #CommunityHealth #HealthAwareness #Wellbeing #PreventiveCare #Science #Innovation #MedicalScience #HealthCareProfessionals #HealthyLifestyle #FutureOfHealth #LifeSaving #HealthForAll #TrustScience #HealthEducation #HealthEquity #HealthAndWellness #HealthcareInnovation

USFDA: Today, the U.S. Food and Drug Administration approved Flu Mist for self- or caregiver-administration. Flu Mist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. Flu Mist is sprayed into the nose and has been used safely and effectively for many years. It was initially approved by the FDA in 2003 for use in individuals 5 through 49 years of age, and in 2007, the FDA approved the use of Flu Mist to include children 2 through 5 years of age. It is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a health care provider. Today’s approval of the first influenza vaccine for self- or caregiver-administration provides a new option for receiving a safe and effective seasonal influenza vaccine potentially with greater convenience, flexibility and accessibility for individuals and families. Said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. Getting vaccinated each year is the best way to prevent influenza, which causes illness in a substantial proportion of the U.S. population every year and may result in serious complications, including hospitalization and death. This approval adds another option for vaccination against influenza disease and demonstrates the FDA’s commitment to advancing public health. #usfda #influenza #vaccine #seasonalvaccine

To face the upsurge ⬆️of Cholera 🧫in some countries 🌏 A new oral vaccine for cholera has received prequalification by the World Health Organization (WHO) on 12 April. The inactivated oral vaccine Euvichol-S has a similar efficacy to existing vaccines but a simplified formulation, allowing opportunities to rapidly increase production capacity. ✅ Anyways, there is NO simple solution to cholera but a combination of preventive efforts among which is the oral vaccine #who #cholera #vaccine

Changes to Flu and COVID-19 Vaccines for 2024-2025 Flu vaccines will be TRIVALENT...for the first time in over a decade. Read our latest article in Pharmacist's Letter to learn more. Just a 2 minute read 😁